← The Lantern · New Carlisle
health · class ii

Lupin Pharmaceuticals Inc. recalls Levothyroxine Sodium Tablets, Lupin, 75 mcg (0.075mg), 1000 Tablets

Baltimore, Maryland 21202 … beginning December 20, 2024, in a drug recall whose distribution included Ohio.

Illustration: a pharmacy counter with pill bottles, a blister pack and one bottle set aside
Illustration · The Lantern

Lupin Pharmaceuticals Inc. began a drug recall on December 20, 2024 whose reported distribution included Ohio. FDA

What the record shows

recalled Levothyroxine Sodium Tablets, Lupin, 75 mcg (0.075mg), 1000 Tablets, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. The stated reason: Failed Impurities/Degradation Specifications: Out of specifications result observed in the drug substance for impurity test during 3-month long term stability study. FDA graded it Class II — use may cause temporary or medically reversible health consequences. Quantity affected: 480 1000-count bottles. The recall is listed as terminated. FDA

1 source

Context

This is one of 8 records of this type (Class Ii) from this source in the year preceding it. FDA

The Lantern holds 60 records from this source in total, and 2880 for New Carlisle across every source. FDA

1 source

By the numbers

  • Date of record: December 20, 2024 FDA
  • Recall number: D-0167-2025 FDA
  • Recalls in this action: 1 FDA
  • Recalling firm: Lupin Pharmaceuticals Inc. FDA
  • Product: Levothyroxine Sodium Tablets, Lupin, 75 mcg (0.075mg), 1000 Tablets, Rx Only, Manufactured for: Lupin Pharmaceuticals… FDA
  • Reason for recall: Failed Impurities/Degradation Specifications: Out of specifications result observed in the drug substance for impurity… FDA
1 source
How we know this:

Assembled mechanically from the source filing and The Lantern's own record database — no AI-written prose. Every figure above appears verbatim in the cited record, which is linked on this page. FDA

The source filing

Recall numberD-0167-2025
Recalls in this action1
Recalling firmLupin Pharmaceuticals Inc.
ProductLevothyroxine Sodium Tablets, Lupin, 75 mcg (0.075mg), 1000 Tablets, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202 United States, Manufactured by: Lupin Limited, Pithampur (M.P)- 454 775 INDIA, NDC# 68180-967-03
Reason for recallFailed Impurities/Degradation Specifications: Out of specifications result observed in the drug substance for impurity test during 3-month long term stability study.
ClassificationClass II — use may cause temporary or medically reversible health consequences
Recall typedrug
Quantity480 1000-count bottles
StatusTerminated
Voluntary or mandatedVoluntary: Firm initiated
Initiated20241220
Reported20250108
DistributionOne US distributor in Ohio.
Firm locationBaltimore, MD, United States
View the original at fda.gov

Published by U.S. Food and Drug Administration (openFDA). This is the agency's public filing as The Lantern received it, shown with its fields named in plain English.

More from Clark County, OHWatch records like this
“Oh, No!” Have we made an error? Report it to us here! We are eager to correct the record.